Acute Lymphoblastic Leukemia: Nursing Notes on Asparaginase Hypersensitivity and Silent Inactivation (SYM6 )

12:45 pm – 2:00 pm
Saturday, October 30
CNE Presentation

Attendees will gain a greater insight into the critical position of the pediatric oncology nurse in monitoring for and managing both ASNase hypersensitivity and the inactivation process which may occur during treatment and be prepared to provide effective education to patients with ALL and their families concerning these issues.

Nursing Credit

MediCom Worldwide, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour. Program Number: 21-038-148


medicom homepage1

Provided by MediCom Worldwide, Inc. This activity is supported by educational grants from Jazz Pharmaceuticals and Servier Pharmaceuticals LLC.


Katelyn Oranges, MSN CRNP CPHON®

Joseph Sciasci, PharmD, BCOP

CNE Hours:
1 Provided by MediCom Worldwid Inc.